Vector-borne diseases (VBDs) represent a significant public health challenge in India, contributing significantly to the country's disease burden. With a diverse range of vectors and climatic conditions conducive to their spread, understanding the extent of this issue is critical for healthcare professionals.
VBDs in India encompass a wide range of illnesses, including malaria, dengue, chikungunya, Japanese encephalitis, and lymphatic filariasis. Each of these diseases presents unique challenges in terms of prevention, diagnosis, and treatment, necessitating a comprehensive understanding of their epidemiology and clinical manifestations.
The epidemiology of VBDs in India is complex, influenced by factors like vector ecology, climate, and socio-economic determinants. Malaria alone accounts for a significant proportion of the disease burden, with an estimated 219 million cases globally in 2017, of which India contributed 4%. Additionally, the country reports the highest dengue burden in the world, with an estimated 100 million cases annually.
The management of VBDs in India faces numerous challenges, including inadequate surveillance, limited resources for vector control, and gaps in public awareness. However, opportunities exist in the form of advancements in diagnostic technologies, vaccine development, and integrated vector management strategies. The role of healthcare professionals is pivotal in leveraging these opportunities to mitigate the VBD burden.
Vector-borne diseases pose a significant public health challenge in India, requiring a comprehensive, multi-faceted approach. Healthcare professionals play a crucial role in this endeavor, from enhancing disease surveillance and diagnosis to driving public education efforts. By deepening our understanding of these diseases and their management, we can work towards reducing their impact on India's health landscape.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation